Clinical data collected from final patient, completing trial • Company plans PMA submission upon receipt of shelf-life stability data • PMA decision anticipated during the 2nd calendar quarter of 2018...
Read more about Avita Medical Announces Last Patient Visit in U.S. Pivotal Trial
SAN DIEGO--(BUSINESS WIRE)--AmpliPhi Biosciences Corporation (NYSE MKT: APHB), a global leader in the development of bacteriophage-based therapies to treat drug-resistant bacterial infections, announces the formation of its Scientific Advisory Board...
Nexvet Reports Financial Results for Second Quarter of Fiscal Year 2017 - link here
23 February 2017: Adherium Limited (ASX : ADR), link here
The Smartinhaler system from New Zealand-based Adherium Ltd. connects with an app to monitor medication adherence, usage, and dosage.
Read more about ‘Smart’ Inhaler System Improves Patient Outcomes in Study
The National Institute for Clinical Excellence (NICE) has recognised digital platform Smartinhaler as the most effective means of improving asthma medication adherence in new guidance.
Read more about NICE recognises Smartinhaler as best practice for asthma care
Digital health technology company, Adherium Limited, has appointed Scott Fleming as Senior Vice President of Business Development, Europe with immediate effect. - link here
Business update call scheduled for today at 4:30 p.m. Eastern
AB-SA01 meets primary endpoints of safety and tolerability and reduces S. aureus bacterial load in all patients
Business update call scheduled for January 4, 2017 at 4:30 p.m. Eastern